Details for New Drug Application (NDA): 020600

✉ Email this page to a colleague

NDA 020600 describes TAZORAC, which is a drug marketed by Allergan and is included in two NDAs. It is available from three suppliers. Additional details are available on the TAZORAC profile page.

The generic ingredient in TAZORAC is tazarotene. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tazarotene profile page.

Summary for 020600

Tradename:	TAZORAC
Applicant:	Allergan
Ingredient:	tazarotene
Patents:	0

Pharmacology for NDA: 020600

Suppliers and Packaging for NDA: 020600

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TAZORAC	tazarotene	GEL;TOPICAL	020600	NDA	Allergan, Inc.	0023-0042	0023-0042-03	1 TUBE in 1 CARTON (0023-0042-03) / 30 g in 1 TUBE
TAZORAC	tazarotene	GEL;TOPICAL	020600	NDA	Allergan, Inc.	0023-0042	0023-0042-10	1 TUBE in 1 CARTON (0023-0042-10) / 100 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	0.05%
Approval Date:	Jun 13, 1997	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	0.1%
Approval Date:	Jun 13, 1997	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020600

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-002	Jun 13, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-002	Jun 13, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-001	Jun 13, 1997	⤷ Sign Up	⤷ Sign Up
Allergan	TAZORAC	tazarotene	GEL;TOPICAL	020600-002	Jun 13, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.